{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:42:24Z","timestamp":1789785744913,"version":"4.0.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013127","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"crossref","award":["13A1-IVPP09"],"award-info":[{"award-number":["13A1-IVPP09"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2823-8-400-001"],"award-info":[{"award-number":["NSTC 112-2823-8-400-001"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Enterovirus A71 (EV-A71) is one of the major causes of hand, foot, and mouth disease (HFMD), primarily affecting children under five. It can lead to neurological and cardiac complications, or even death, in some cases. Inactivated monovalent vaccines have been licensed in China and Taiwan; however, the stability of EV-A71 vaccines is often compromised by factors such as extreme temperatures or ultraviolet (UV) irradiation. Currently, no commercially available tools can assess the stability of EV-A71 throughout vaccine development. In this study, we report the development of a monoclonal antibody (mAb), NHRI2016\u20131, which can be used in in vitro immunoassays to evaluate EV-A71 vaccine potency and effectiveness. NHRI2016\u20131 exclusively recognizes effective EV-A71 antigens in in vitro potency assays. Similarly, rat experiment confirmed that effective vaccine antigens could induce neutralizing antibodies, while ineffective antigens could not. Thus, NHRI2016\u20131 shows potential for correlating in vitro potency with in vivo immunogenicity of EV-A71 vaccine antigens. These data suggest that NHRI2016\u20131 could be a promising tool for characterizing EV-A71 vaccines and monitoring vaccine potency.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013127","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:10:26Z","timestamp":1748981426000},"page":"e0013127","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of a novel EV-A71 monoclonal antibody for monitoring vaccine potency"],"prefix":"10.1371","volume":"19","author":[{"given":"Thi-Hong-Loc","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yuan","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-3370","authenticated-orcid":true,"given":"Min-Shi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"5","key":"pntd.0013127.ref001","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/14760584.2016.1138862","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"15","author":"QY Mao","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"pntd.0013127.ref002","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4269\/ajtmh.2007.77.188","article-title":"An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan","volume":"77","author":"S-C Chen","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013127.ref003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13104-016-1973-y","article-title":"A literature review and case report of hand, foot and mouth disease in an immunocompetent adult","volume":"9","author":"C Oma\u00f1a-Cepeda","year":"2016","journal-title":"BMC Res Notes"},{"issue":"3","key":"pntd.0013127.ref004","article-title":"Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody","volume":"12","author":"X Ye","year":"2016","journal-title":"PLoS Pathog"},{"key":"pntd.0013127.ref005","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.73.12.9969-9975.1999","article-title":"Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998","volume":"73","author":"BA Brown","year":"1999","journal-title":"J Virol"},{"issue":"26","key":"pntd.0013127.ref006","doi-asserted-by":"crossref","first-page":"30565","DOI":"10.2807\/1560-7917.ES.2017.22.26.30565","article-title":"Co-circulation of multiple subtypes of enterovirus A71 (EV- A71) genotype C, including novel recombinants characterised by use of whole genome sequencing (WGS), Denmark 2016","volume":"22","author":"SE Midgley","year":"2017","journal-title":"Euro Surveill"},{"key":"pntd.0013127.ref007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Y Zhang","year":"2010","journal-title":"Virol J"},{"issue":"2","key":"pntd.0013127.ref008","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1442-200x.2004.01868.x","article-title":"Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region","volume":"46","author":"H Shimizu","year":"2004","journal-title":"Pediatr Int"},{"issue":"4","key":"pntd.0013127.ref009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12250-011-3195-8","article-title":"Hand foot and mouth disease due to enterovirus 71 in Malaysia","volume":"26","author":"KB Chua","year":"2011","journal-title":"Virol Sin"},{"issue":"2","key":"pntd.0013127.ref010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007","volume":"38","author":"LW Ang","year":"2009","journal-title":"Ann Acad Med Singap"},{"issue":"2","key":"pntd.0013127.ref011","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jmv.20534","article-title":"Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71","volume":"78","author":"K-H Lin","year":"2006","journal-title":"J Med Virol"},{"issue":"11","key":"pntd.0013127.ref012","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3201\/eid1311.070632","article-title":"Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005","volume":"13","author":"P Van Tu","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"pntd.0013127.ref013","article-title":"The cross-neutralizing activity of enterovirus 71 subgenotype C4 vaccine in healthy Chinese infants and children","volume":"8","author":"Q Mao","year":"2013","journal-title":"PLoS One"},{"issue":"10336","key":"pntd.0013127.ref014","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(22)00313-0","article-title":"Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"399","author":"TT Nguyen","year":"2022","journal-title":"Lancet"},{"key":"pntd.0013127.ref015","doi-asserted-by":"crossref","first-page":"100370","DOI":"10.1016\/j.lanwpc.2021.100370","article-title":"Changing epidemiology of hand, foot, and mouth disease in China, 2013-2019: a population-based study","volume":"20","author":"J Hong","year":"2022","journal-title":"The Lancet Regional Health-Western Pacific"},{"issue":"3","key":"pntd.0013127.ref016","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jiac.2022.12.006","article-title":"Analysis of the epidemiological trends of enterovirus A in Asia and Europe","volume":"29","author":"X Qiao","year":"2023","journal-title":"J Infect Chemother"},{"issue":"6","key":"pntd.0013127.ref017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"J Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"pntd.0013127.ref018","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.vaccine.2018.01.041","article-title":"Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses","volume":"36","author":"M-Y Chia","year":"2018","journal-title":"Vaccine"},{"key":"pntd.0013127.ref019","volume-title":"Temperature Sensitivity of Vaccines","author":"World Health Organization (WHO).","year":"2006"},{"issue":"26","key":"pntd.0013127.ref020","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"C-C Liu","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"pntd.0013127.ref021","article-title":"Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development","volume":"8","author":"M-Y Chia","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013127.ref022","first-page":"3","article-title":"Production of monoclonal antibodies. The effect of hybridoma concentration on the yield of antibody-producing clones","volume":"96","author":"E Hadas","year":"1987","journal-title":"J Immunol Methods"},{"issue":"3","key":"pntd.0013127.ref023","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent Endpoints12","volume":"27","author":"LJ Reed","year":"1938","journal-title":"American Journal of Epidemiology"},{"key":"pntd.0013127.ref024","unstructured":"Tedcastle A, Mao Q, Hockley J, Pegg E, Gao F, Liang Z, et al. Report on the WHO collaborative study to establish the 1st International Standard for Enterovirus A71 inactivated vaccine. 2019."},{"key":"pntd.0013127.ref025","first-page":"148","article-title":"Antigen recognition by B-cell and T-cell receptors","volume-title":"Janeway\u2019s Immunobiology","author":"K Murphy","year":"2017"},{"issue":"4720","key":"pntd.0013127.ref026","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.2994218","article-title":"Three-dimensional structure of poliovirus at 2.9 A resolution","volume":"229","author":"JM Hogle","year":"1985","journal-title":"Science"},{"issue":"50","key":"pntd.0013127.ref027","doi-asserted-by":"crossref","first-page":"20063","DOI":"10.1073\/pnas.1312128110","article-title":"Uncoating of common cold virus is preceded by RNA switching as determined by X-ray and cryo-EM analyses of the subviral A-particle","volume":"110","author":"A Pickl-Herk","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pntd.0013127.ref028","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-022-00470-4","article-title":"Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies","volume":"7","author":"G Sanyal","year":"2022","journal-title":"NPJ Vaccines"},{"key":"pntd.0013127.ref029","unstructured":"World Health Organization (WHO). Guidelines on Stability Evaluation of Vaccines, Annex 3, TRS No 962. 2011."},{"issue":"11","key":"pntd.0013127.ref030","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/acsphotonics.0c01245","article-title":"A Critical Review on Ultraviolet Disinfection Systems against COVID-19 Outbreak: Applicability, Validation, and Safety Considerations","volume":"7","author":"M Raeiszadeh","year":"2020","journal-title":"ACS Photonics"},{"key":"pntd.0013127.ref031","first-page":"2283","article-title":"Susceptibility on enveloped and non-enveloped viruses to ultraviolet light-emitting diode (UV-LED) irradiation and implications for virus inactivation mechanisms","volume":"9","author":"VD Canh","year":"2023","journal-title":"Environ Sci: Water Res Technol"},{"issue":"1","key":"pntd.0013127.ref032","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1038\/s41598-021-93231-7","article-title":"UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins","volume":"11","author":"C-W Lo","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"pntd.0013127.ref033","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.1320624111","article-title":"Neutralizing antibodies can initiate genome release from human enterovirus 71","volume":"111","author":"P Plevka","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pntd.0013127.ref034","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41467-017-00736-9","article-title":"Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children","volume":"8","author":"K-Y Arthur Huang","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"pntd.0013127.ref035","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2009.09.103","article-title":"Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides","volume":"390","author":"X Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"pntd.0013127.ref036","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/JVI.03098-14","article-title":"The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro","volume":"89","author":"KL Shingler","year":"2015","journal-title":"J Virol"},{"issue":"5","key":"pntd.0013127.ref037","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1371\/journal.pntd.0002895","article-title":"A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved \u201cknob\u201d region of VP3 protein","volume":"8","author":"TK Kiener","year":"2014","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"4","key":"pntd.0013127.ref038","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"A-H Chou","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"pntd.0013127.ref039","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"D Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"pntd.0013127.ref040","volume-title":"Summary of stability data for licensed vaccines","author":"D Kristensen","year":"2012"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013127","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:02:53Z","timestamp":1749664973000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013127"}},"subtitle":[],"editor":[{"given":"Ran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013127","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0013127","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}